# Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating the Healthcare Staffing Landscape with a 19.90% Potential Upside

- Link: https://www.directorstalkinterviews.com/cross-country-healthcare-inc-ccrn-stock-analysis-navigating-the-healthcare-staffing-landscape-with-a-19-90-potential-upside/4121246882
- Published: 2026-03-27T11:26:25+00:00
- Author: Madison Wilson

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands out as a key player in the 
healthcare sector, specifically within the medical care facilities industry. With
a market capitalization of $318.75 million, the company is carving its niche by 
providing comprehensive talent management services to healthcare clients across 
the United States. As an investor, understanding the financial and operational dynamics
of this company is crucial, especially given its potential upside of 19.90% as indicated
by analyst ratings.

The current stock price of Cross Country Healthcare is $9.73, slightly down by 0.06
or 0.01%. This positions it well within its 52-week range of $7.53 to $15.11, offering
a point of entry that could be appealing to value-focused investors. The stock’s
forward price-to-earnings (P/E) ratio stands at 34.75, suggesting expectations of
future earnings growth despite the current challenges. Notably, traditional valuation
metrics such as the trailing P/E ratio and the price/book ratio are unavailable,
signaling a period of adjustment or strategic realignment for the company.

Revenue growth has experienced a significant decline of 23.60%, which may raise 
concerns regarding the company’s ability to sustain its financial performance. This
decline is further reflected in an earnings per share (EPS) of -2.93 and a return
on equity (ROE) of -25.57%, indicating that the company is currently operating at
a loss. However, Cross Country Healthcare’s free cash flow of $42.77 million suggests
a robust cash position that could support strategic investments and operational 
stability.

The company’s dividend yield is currently non-existent, with a payout ratio of 0.00%,
aligning with its focus on reinvesting earnings to bolster growth and stabilize 
operations. This reinvestment strategy might appeal to growth-oriented investors
who prioritize potential capital gains over immediate income.

Analyst sentiment reveals a mixed yet cautiously optimistic outlook, with three 
buy ratings and six hold ratings. The target price range of $10.00 to $15.00, with
an average target of $11.67, supports a potential upside of nearly 20%. This potential
is a key consideration for investors assessing the risk-reward balance of adding
CCRN to their portfolios.

Technical indicators present a nuanced view of the stock’s current momentum. The
50-day moving average of $9.03 suggests a short-term bullish trend, although the
200-day moving average of $11.25 highlights a longer-term downward trajectory that
investors should monitor closely. The Relative Strength Index (RSI) at 29.21 indicates
that the stock is in oversold territory, potentially signaling a buying opportunity
if the company’s fundamentals improve.

Cross Country Healthcare, founded in 1986 and headquartered in Boca Raton, Florida,
operates through two main segments: Nurse and Allied Staffing, and Physician Staffing.
The firm provides a wide range of staffing solutions, from travel nurses to physician
assistants, catering to diverse healthcare facilities including hospitals, government
facilities, and outpatient clinics. This breadth of services positions the company
to capture various market segments and respond dynamically to shifting healthcare
demands.

As healthcare staffing remains a critical component of the broader healthcare system,
Cross Country Healthcare’s strategic focus on delivering value-added solutions could
drive future growth. Investors should weigh the company’s current financial challenges
against its operational strengths and market opportunities, particularly in light
of the potential upside identified by analysts. As with any investment, due diligence
and consideration of personal risk tolerance are essential when evaluating CCRN’s
position in your portfolio.

Share on: